Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03911700 · ClinicalTrials.gov registry record · NA
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
A NA study of Open Midline Laparotomy, sponsored by C. R. Bard.
- Recruiting
- Registry status
- NA
- Development phase
- 477
- Enrollment target
- 20
- Study locations
NCT03911700 is a NA study of Open Midline Laparotomy that is actively recruiting participants, run by C. R. Bard. The registered enrollment target is 477 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT03911700, a NA study of Open Midline Laparotomy, is actively recruiting participants, sponsored by C. R. Bard.
- RECRUITING
- Registry status
- NA
- Development phase
- 477 participants
- Enrollment target
- 20
- Study locations
Study Summary
This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surgery.
Conditions Studied
Interventions
- DEVICE Phasix™ Mesh
Study Locations (20)
Missouri
- St. Luke's Hospital - Kansas City
- Cox Health - Springfield
- Washington University - St Louis
California
- Keck Medical Center of USC - Los Angeles
- University of California San Francisco - San Francisco
Connecticut
- Hartford Hospital - Hartford
- St. Francis Hospital and Medical Center - Hartford
Minnesota
- Minneapolis VA Health Care System - Minneapolis
- University of Minnesota - Minneapolis
Nebraska
- Nebraska Medical Center - Omaha
- Nebraska Methodist Hospital - Omaha
Arizona
- Dignity Health - Phoenix
Georgia
- Emory University - Atlanta
Illinois
- OSF Saint Francis Medical Center - Peoria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2019-12-12 |
| Est. Completion | 2031-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03911700
The ClinicalTrials.gov registry entry for NCT03911700 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 477 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Open Midline Laparotomy appearing as the primary indexed condition, and to 1 intervention - of which Phasix™ Mesh is the first listed.
NCT03911700 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Missouri, California, Connecticut.
Frequently Asked Questions
What is clinical trial NCT03911700 about?
NCT03911700 is a clinical study titled "Prophylactic Reinforcement of Ventral Abdominal Incisions Trial". This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surgery.
What is the current status of trial NCT03911700?
This trial is currently recruiting. It is a NA study. The enrollment target is 477 participants. The study started on 2019-12-12. Estimated completion is 2031-12.
What conditions does trial NCT03911700 study?
This clinical trial studies the following conditions: Open Midline Laparotomy.
What interventions are being tested in trial NCT03911700?
The interventions under investigation include: Phasix™ Mesh (DEVICE).
Who is sponsoring clinical trial NCT03911700?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03911700 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.